Speaker illustration

Associate Professor Michael Blazing

Duke Clinical Research Institute, Durham (United States of America)

Comparative efficacy of ezetimibe plus simvastatin combined therapy vs. simvastatin monotherapy for individuals with reduced estimated glomerular filtration rate

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session: Lipid-lowering agents - New perspectives

Thumbnail

This platform is supported by

logo Novo Nordisk